Hepatic involvement in children with acute bronchiolitis

doi:10.4254/wjh.v14.i10.1907

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3807)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

112

WORD

HTML

1932

Figures (1-3)

234

Tables (1-4)

147

Sum=2456

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

168

Download

537

Sum=705

Publishing Process of This Article

Item

Count

Browse

175

Download

471

Sum=646

Oct 27, 2022 (publication date) through Apr 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Oct 27, 2022; 14(10): 1907-1919
Published online Oct 27, 2022. doi: 10.4254/wjh.v14.i10.1907

Table 1 Demographic data of children with acute bronchiolitis (n = 166)

Demographic data		No. of patients (%)
Sex	Male	93 (56)
Sex	Female	73 (44)
Nationality	Bahraini	117 (70.5)
Nationality	Other	49 (29.5)
Gestational age (n = 140)	Term	111 (79.3)
Gestational age (n = 140)	Preterm	29 (20.7)
Age at presentation (mo), median (IQR)		3.4 (1.1-12.4)
Current age (mo), median (IQR)		30.3 (28.31-39.8)
Length of stay (d), median (IQR)		6.0 (3.0-11.0)

Values are presented as n (%) for categorical variables and median (interquartile range) for continuous variables. IQR: Interquartile range.

Table 2 Results of laboratory investigations in the 166 children who presented with acute bronchiolitis

Variable	Normal range	Mean	SD	Median	Minimum	Maximum	Tested patients (%)
White blood cell count (× 10⁹/L)	3.6-9.6	10.8	5.4	9.7	0.80	27.8	166 (100)
Hemoglobin level (g/dL)	12.0-14.5	11.5	2.3	11.0	5.7	20.0	166 (100)
Platelet count (× 10⁹/L)	150-400	410	179.7	383.5	14.5	971.0	166 (100)
Total serum protein (g/L)	64-82	57.8	8.7	58.0	25.0	96.0	161 (97)
Serum albumin (g/L)	38-54	41.5	10.7	41.0	17.0	143.0	161 (97)
Serum globulin (g/L)	15-30	18.0	10.7	17.0	6.0	140.0	161 (97)
Total bilirubin (µmol/L)	5-21	37.4	61.2	10.0	2.0	482.0	161 (97)
Direct bilirubin (µmol/L)	0-5	12.0	14.4	11.0	1.0	122.0	71 (42.8)
Indirect bilirubin (µmol/L)	< 18	56.0	46.0	27.0	1.0	454.0	71 (42.8)
Alkaline phosphatase (U/L)	150-420	242.6	141.7	198.0	58.0	841.0	161 (97)
Alanine aminotransferase (U/L)	< 41	25.6	30.2	19.0	6.0	247.0	161 (97)
Gamma glutamyl transferase (U/L)	< 18	63.2	80.0	32.0	6.0	526.0	145 (87.3)
Prothrombin time	10-14	13.7	2.8	12.9	9.5	25.2	46 (27.7)
INR	0.6-1.2	1.1	0.3	1.1	0.79	2.2	46 (27.7)
PTT (sec)	28-43	28.2	9.7	26.8	13.2	63.3	46 (27.7)
Fibrinogen (mg/dl)	217-496	285.9	213.8	233.8	0.0	1115.2	34 (20.48)
Thrombin time (sec)	15.6 -18.4	17.9	4.1	17.3	4.1	13.0	33 (19.87)
Random blood sugar (mmol/L)	3.6-8.9	5.7	1.4	5.2	4.0	10.0	53 (32)
Ammonia (µmol/L)	11-35	80.6	61.2	62.0	7.0	230.0	11 (6.6)
Lactic acid (mmol/L)	0.5-2.2	3.1	3.3	1.5	1.0	10.0	7 (4.2)
Lactate dehydrogenase (units/L)	250-650	1030.1	1281.9	531.5	3.0	3509.0	6 (3.6)
Iron profile (µg/dL)	11.6-31.3	9.4	5.7	8.0	4.0	19.0	9 (5.4)
CRP (mg/L)	0.3	26.8	39.2	9.5	10.0	297.0	166 (100)

SD: Standard deviation; INR: International normalized ratio; PTT: Partial thromboplastin time; CRP: C-reactive protein.

Table 3 Comparison of patients with and without liver function test abnormalities

Variable		Alanine aminotransferase level (n = 161)		P value
Variable		High (> 41 U/L), 14 (8.7)	Normal (≤ 41 U/L), 147 (91.3)	P value
Sex	Female	9 (64.3)	61(41.5)	0.157^a
	Male	5 (35.7)	86 (58.5)
Nationality	Bahraini	9 (64.3)	104 (70.7)	0.760^a
	Non-Bahraini	5 (35.7)	43 (29.3)
Gestational age (n = 135)	Term	8 (57.1)	98 (66.7)	0.683
	Preterm	1 (7.1)	28 (19.0)
Age at presentation (mo), mean ± SD		10.1 ± 12.8	10.6 ± 17.3	0.535^b
Age at the time of study (mo), mean ± SD		37.5 ± 13.2	37.8 ± 17.5	0.394^b
Length of hospital stay (d), mean ± SD		18.0 ± 19.3	13.4 ± 41.1	0.025^b
History of fever		9 (7.9)	105 (92.1)	0.552^a
White blood cell count (× 10⁹/L), mean ± SD		12.2 ± 7.0	10.6 ± 5.3	0.764^b
Hemoglobin (g/dL), mean ± SD		11.6 ± 2.1	11.5 ± 2.4	0.796^b
Platelet count (× 10⁹/L), mean ± SD		335.4 ± 194.8	417.6 ± 178.5	0.109^b
Total serum protein (g/L), mean ± SD		56.6 ± 7.3	57.9 ± 8.9	0.895^b
Serum globulin (g/L), mean ± SD		16.71 ± 3.69	18.1 ± 11.2	0.801^b
Serum albumin (g/L), mean ± SD		39.86 ± 5.89	41.63 ± 11.1	0.971^b
Total bilirubin (µmol/L), mean ± SD		29.4 ± 41.2	38.11 ± 62.81	0.794^b
Direct bilirubin (µmol/L), (n = 71), mean ± SD		24.1 ± 39.9	10.5 ± 5.7	0.722^b
Indirect bilirubin (µmol/L), (n = 71), mean ± SD		22.5 ± 17.9	62.0 ± 75.1	0.184^b
Alkaline phosphatase (U/L), mean ± SD		271.9 ± 217.2	239.9 ± 133.1	0.935^b
Gamma-glutamyl transferase (U/L), (n = 145), mean ± SD		92.4 ± 88.2	60.6 ± 79.0	0.080^b
Prothrombin time, (n = 46), mean ± SD		13.2 ± 1.6	13.8 ± 3.0	0.809^b
INR, (n = 46), mean ± SD		1.1 ± 0.1	1.2 ± 0.3	0.831^b
PTT, (n = 46), mean ± SD		25.5 ± 4.9	28.8 ± 10.4	0.579^b
Fibrinogen, (n = 34), mean ± SD		326.4 ± 387.2	277.3 ± 166.4	0.581^b
Thrombin time, (n = 33), mean ± SD		21.4 ± 7.3	16.9 ± 2.0	0.131^b
Random blood glucose, (n = 52), mean ± SD		6.0 ± 1.0	6.0 ± 1.0	0.905^b
Positive blood culture (n = 127)		2 (14.3)	10 (6.8)	0.278^a
Positive urine culture (n = 88)		3 (21.4)	4 (2.7)	0.030^a
Positive cerebrospinal fluid culture (n = 23)		0 (0.0)	1.0 (0.7)	1.000^a
Positive RSV test (n = 159)		6 (42.9)	46 (31.3)	0.356^a
Antibiotic use (n = 157)		11 (78.6)	115 (78.2)	1.000^a
Complications		2 (14.3)	28 (19)	1.000^a
Admission to the intensive care unit		1 (7.1)	10 (6.8)	1.000^a
Mortality		1 (7.1)	8 (5.4)	0.569^a

^aFisher’s exact test was used for categorical variables.

^bMann-Whitney U test was used for continuous variables.

Values are presented as n (%) or mean ± SD. Bold indicates a statistically significant difference with P < 0.05. SD: Standard deviation; INR: International normalized ratio; PTT: Partial thromboplastin time; RSV: Respiratory syncytial virus.

Table 4 Comparison of patients with acute bronchiolitis who were tested for liver enzymes at the time of presentation and at the time of follow up

Variable	Normal range	n	At the time of the presentation	At the time of follow-up	P value^a
Total serum protein (g/L)	64-82	65	59.0 ± 11.0	62.0 ± 11.0	0.011
Serum albumin (g/L)	38-54	65	42.0 ± 9.0	42.5 ± 7.0	0.467
Serum globulin (g/L)	15-30	65	18.0 ± 5.0	20.0 ± 6.0	0.008
Total bilirubin (µmol/L)	5-21	64	37.0 ± 49.0	28.0 ± 91.0	0.376
Direct bilirubin (µmol/L)	0-5	16	18.0 ± 28.0	51.0 ± 157.0	0.322
Indirect bilirubin (µmol/L)	< 18	15	56.0 ± 46.0	35.0 ± 50.0	0.103
Alkaline phosphatase (U/L)	150-420	64	240.0 ± 143.0	242.0 ± 121.0	0.897
Alanine aminotransferase (U/L)	< 41	61	31.0 ± 43.0	42.0 ± 88.0	0.371
Gamma-glutamyl transferase (U/L)	< 18	50	61.0 ± 75.0	41.0 ± 91.0	0.234

^aP value was calculated by the paired t-test.

Citation: Isa HM, Hasan AZ, Khalifa SI, Alhewaizem SS, Mahroofi AD, Alkhan FN, Al-Beltagi M. Hepatic involvement in children with acute bronchiolitis. World J Hepatol 2022; 14(10): 1907-1919
URL: https://www.wjgnet.com/1948-5182/full/v14/i10/1907.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i10.1907